Literature DB >> 28450574

A major turning point in NK/T-cell lymphoma?

Arnaud Jaccard1, Olivier Hermine2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28450574     DOI： 10.1182/blood-2017-03-769075

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

Review 1.  Treatment Advances in EBV Related Lymphoproliferative Diseases.

Authors:  Kebing Lv; Ting Yin; Min Yu; Zhiwei Chen; Yulan Zhou; Fei Li
Journal:  Front Oncol       Date:  2022-04-19       Impact factor: 5.738

Review 2.  Molecular pathogenic pathways in extranodal NK/T cell lymphoma.

Authors:  Sanjay de Mel; Susan Swee-Shan Hue; Anand D Jeyasekharan; Wee-Joo Chng; Siok-Bian Ng
Journal:  J Hematol Oncol       Date:  2019-04-02       Impact factor: 17.388

3.  sATP‑binding cassette subfamily G member 2 enhances the multidrug resistance properties of human nasal natural killer/T cell lymphoma side population cells.

Authors:  Shaoxuan Wu; Xudong Zhang; Meng Dong; Zhenzhen Yang; Mingzhi Zhang; Qingjiang Chen
Journal:  Oncol Rep       Date:  2020-08-10       Impact factor: 3.906

Review 4.  Updating targets for natural killer/T-cell lymphoma immunotherapy.

Authors:  Weili Xue; Mingzhi Zhang
Journal:  Cancer Biol Med       Date:  2021-02-15       Impact factor: 4.248

Review 5.  The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation.

Authors:  Sanjay de Mel; Gwyneth Shook-Ting Soon; Yingting Mok; Tae-Hoon Chung; Anand D Jeyasekharan; Wee-Joo Chng; Siok-Bian Ng
Journal:  Int J Mol Sci       Date:  2018-06-30       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.